Ingest podcast

Artwork

Science Podcasting Education Medicine The Primary Care Society for Gastroenterology

Player FM - Internet Radio Done Right

Ajouté il y a deux ans

Contenu fourni par The Primary Care Society for Gastroenterology. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par The Primary Care Society for Gastroenterology ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.

<

<div class="span index">1</div> <span><a class="" data-remote="true" data-type="html" href="/series/all-about-change">All About Change</a></span>

<div class="span index">1</div> <span><a class="" data-remote="true" data-type="html" href="/series/all-about-change">All About Change</a></span> podcast artwork

<div class="span index">1</div> <span><a class="" data-remote="true" data-type="html" href="/series/all-about-change">All About Change</a></span> podcast artwork

1
All About Change

il y a environ 6 joursil y a 6d ago

Chaque mois+

How do we build an inclusive world? Hear intimate and in-depth conversations with changemakers on disability rights, youth mental health advocacy, prison reform, grassroots activism, and more. First-hand stories about activism, change, and courage from people who are changing the world: from how a teen mom became the Planned Parenthood CEO, to NBA player Kevin Love on mental health in professional sports, to Beetlejuice actress Geena Davis on Hollywood’s role in women’s rights. All About Change is hosted by Jay Ruderman, whose life’s work is seeking social justice and inclusion for people with disabilities worldwide. Join Jay as he interviews iconic guests who have gone through adversity and harnessed their experiences to better the world. This show ultimately offers the message of hope that we need to keep going. All About Change is a production of the Ruderman Family Foundation. Listen and subscribe to All About Change wherever you get podcasts. https://allaboutchangepodcast.com/

Ingest

Partager

maison des série•Feed

Contenu fourni par The Primary Care Society for Gastroenterology. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par The Primary Care Society for Gastroenterology ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.

Dr Charlie Andrews, a GP from Bath and PCSG Committee Member, explores a range of gastroenterology topics from a GPs perspective. The focus of the series covers when to suspect, how to diagnose, when to refer and how to support your patients.

… continue reading

30 episodes

#Science #Podcasting Education #Medicine #The Primary Care Society for Gastroenterology

Artwork

Ingest

updated il y a environ 19 jours

Partager

maison des série•Feed

Contenu fourni par The Primary Care Society for Gastroenterology. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par The Primary Care Society for Gastroenterology ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.

Dr Charlie Andrews, a GP from Bath and PCSG Committee Member, explores a range of gastroenterology topics from a GPs perspective. The focus of the series covers when to suspect, how to diagnose, when to refer and how to support your patients.

… continue reading

30 episodes

#Science #Podcasting Education #Medicine #The Primary Care Society for Gastroenterology

ทุกตอน

×

I

Ingest

Ingest podcast artwork

1
Neuroendocrine Cancer – The Expert Patient 43:29

il y a environ 19 jours43:29

43:29

The episode features Dr. David Bartlett, a retired GP and neuroendocrine cancer patient, offering a dual perspective as both clinician and patient. Key Learnings from this episode. Patient Experience and Diagnostic Challenges Dr. Bartlett’s symptoms began with severe, intermittent abdominal pain, starting in 2001, but he did not seek medical help for several years due to a combination of stoicism, not wanting to trouble others, and a belief in the commonality of benign causes. Over 15 years, he experienced repeated misdiagnoses, primarily being labeled as having irritable bowel syndrome (IBS) despite atypical features (severe pain, minimal bowel habit change, and no systemic symptoms). Multiple opinions and investigations (including ultrasounds and CT scans) failed to identify the underlying cause, with a key scan being misread by local radiologists. The correct diagnosis of a small bowel neuroendocrine tumour was only made after a tertiary centre re-examined previous scans, highlighting the importance of specialist review and persistence in unexplained cases. Clinical Red Flags and Symptomatology Dr. Bartlett’s case underscores that neuroendocrine tumors can present with isolated, severe abdominal pain without classic red flags (vomiting, weight loss, significant bowel changes)[1]. He retrospectively identified subtle signs of carcinoid syndrome (flushing, one episode of profound diarrhoea, and skin changes), which are present in only about 10% of small bowel neuroendocrine tumour cases. The lack of awareness about neuroendocrine tumors, even among experienced clinicians, contributed to the diagnostic delay[1]. Lessons for Primary Care and Clinicians The story illustrates the risk of anchoring on common diagnoses (like IBS) and the need to reconsider the diagnosis when symptoms are severe, persistent, or atypical. It highlights the value of listening to the patient’s narrative, especially when symptoms do not fit classic patterns, and the importance of considering rare conditions in the differential diagnosis. The episode emphasises the need for ongoing education about neuroendocrine tumours and the importance of keeping rare but serious conditions on the diagnostic radar in primary care. Management Insights Standard treatment for small bowel neuroendocrine tumours often includes monthly somatostatin analog injections (e.g., lanreotide). Surgical intervention may be considered, but it carries specific risks such as carcinoid crisis, requiring specialised perioperative management. The decision for surgery is individualised, weighing potential symptomatic improvement against procedural risks. Systemic and Human Factors Dr. Bartlett’s experience reflects how personal traits (stoicism, reluctance to seek help) and systemic issues (misinterpretation of scans, diagnostic inertia) can delay diagnosis. The narrative also demonstrates the importance of patient advocacy, persistence, and the value of second (or third) opinions, especially in complex or unresolved cases. Educational Value The episode serves as a reminder for clinicians to maintain a broad differential, revisit diagnoses when the clinical picture changes, and to be aware of their own cognitive biases. It also advocates for the inclusion of patient voices in medical education to better understand the lived experience and challenges of rare diseases like neuroendocrine cancer. Summary Table: Key Learnings ThemeKey PointsDiagnostic Delay15 years from symptom onset to diagnosis; misdiagnosed as IBS despite atypical featuresSymptomatologySevere, intermittent abdominal pain; minimal bowel changes; subtle carcinoid syndromeClinical LessonsImportance of specialist review, reconsidering diagnoses, and listening to patient storiesManagementUse of somatostatin analogs; surgery considered but with specific risksSystemic FactorsImpact of stoicism, misread scans, and diagnostic inertiaEducational TakeawayNeed for awareness of rare conditions and patient-centered education These insights from the transcript highlight the complexities of diagnosing and managing neuroendocrine cancer, especially in primary care, and the critical role of patient experience in improving clinical practice.…

I

Ingest

Ingest podcast artwork

1
Pancreatic Conditions Part 2 – Malignant 43:36

il y a 6 weeks43:36

43:36

Dr Charlie Andrews talks to Dr John Leeds. John Leeds is a Consultant Pancreaticobiliary Physician and Endoscopist based at the Freeman Hospital in Newcastle and an Honorary Clinical Senior Lecturer based in the Population Health Sciences Institute at Newcastle University. He is involved in research in pancreaticobiliary disorders including benign and malignant conditions as well as outcomes from therapeutic/advanced endoscopy. John is a member of the British Society of Gastroenterology and Pancreatic Society of Great Britain and Ireland. He serves on the endoscopy and Pancreas committees for BSG and is the website lead for PSGBI. He is also a founder member of the BSG Pancreas Clinical Research Group which is coordinating research for the society. Key Learnings from this episode: Challenges in Early Detection of Pancreatic Cancer • Pancreatic cancer is often diagnosed at an advanced stage due to the deep location of the pancreas and the lack of early symptoms. • Tumors in the body and tail of the pancreas can grow significantly before causing symptoms, often invading major arteries or veins, making them inoperable. • Tumors in the head of the pancreas may present earlier due to bile duct obstruction, leading to jaundice, but even these are often detected late. Early Symptoms and Red Flags • Early symptoms are vague or absent, making early diagnosis difficult. • Possible early indicators include: • Weight loss (often a sign of advanced disease). • New-onset diabetes, particularly in individuals with a normal BMI or without typical risk factors for type 2 diabetes. • Jaundice, which is a significant red flag and often indicates a serious underlying condition. • Classic signs like painless jaundice and Courvoisier’s sign (palpable gallbladder) are important but not always present. Limitations of Current Screening Methods • There is no reliable biomarker or screening test for pancreatic cancer: • CA19-9 is not suitable as a screening tool due to its lack of specificity (elevated in other conditions). • Imaging techniques like CT scans or MRIs are used but have limitations, including incidental findings that may lead to unnecessary anxiety (“scanxiety”) and over-investigation. • Screening is currently limited to high-risk groups, such as those with familial pancreatic cancer syndromes or hereditary pancreatitis. High-Risk Groups for Screening • Familial pancreatic cancer accounts for less than 10% of cases. Criteria for screening include: • Multiple family members with pancreatic cancer, especially diagnosed under age 50–60. • Genetic syndromes like BRCA mutations, familial adenomatous polyposis (FAP), and Peutz-Jeghers syndrome. • Hereditary pancreatitis patients have an increased risk but are harder to screen due to pre-existing pancreatic abnormalities. Emerging Research and Future Directions • Studies are exploring potential biomarkers, such as microbiome signatures in the pancreas, which might help identify high-risk individuals in the future. • Trials like the EuroPAC study focus on surveillance protocols for high-risk individuals using imaging techniques like MRI or endoscopic ultrasound. • Research into new-onset diabetes as a potential marker for pancreatic cancer is ongoing but currently has a low yield due to the high prevalence of type 2 diabetes unrelated to malignancy. Considerations for Screening and Surveillance • Screening should be carefully targeted to avoid over-diagnosis and unnecessary investigations. • The psychological impact of screening (e.g., anxiety from incidental findings) must be considered. • Smoking cessation is emphasized as smoking is a significant risk factor for pancreatic cancer. Advances in Treatment Approaches • PET-CT scans are increasingly used to detect systemic disease that might not be evident on standard CT scans. • Neoadjuvant treatments (therapy before surgery) are being explored for cases where systemic spread is suspected. Conclusion Pancreatic cancer remains challenging to detect early due to vague symptoms and limited screening tools. Current efforts focus on identifying high-risk groups for targeted surveillance and advancing research into biomarkers and new diagnostic strategies. Early detection remains critical for improving outcomes, but significant barriers persist.…

I

Ingest

Ingest podcast artwork

1
Pancreatic Conditions Part 1 – Benign 1:08:41

il y a 8 weeks1:08:41

1:08:41

Dr Charlie Andrews talks to Dr John Leeds. John Leeds is a Consultant Pancreaticobiliary Physician and Endoscopist based at the Freeman Hospital in Newcastle and an Honorary Clinical Senior Lecturer based in the Population Health Sciences Institute at Newcastle University. He is involved in research in pancreaticobiliary disorders including benign and malignant conditions as well as outcomes from therapeutic/advanced endoscopy. John is a member of the British Society of Gastroenterology and Pancreatic Society of Great Britain and Ireland. He serves on the endoscopy and Pancreas committees for BSG and is the website lead for PSGBI. He is also a founder member of the BSG Pancreas Clinical Research Group which is coordinating research for the society.…

I

Ingest

Ingest podcast artwork

1
IBS Part 2 – Management 45:15

il y a 12 weeks45:15

45:15

Charlie Andrews talks to Dr Chris Black about the management of IBS. This podcast provides key insights into managing Irritable Bowel Syndrome (IBS), emphasising a multidisciplinary and individualised approach to care. Here are the main takeaways: 1. Multidisciplinary and Integrative Care IBS management requires a holistic, patient-centered approach involving dietitians, behavioral therapists, and gastroenterologists. This "team sport" approach expands treatment options and tailors care to individual patient needs 1 . Integrative care, which combines dietary, psychological, and medical interventions, has been shown to improve symptoms, psychological well-being, and quality of life for IBS patients 1 . 2. Personalised Treatment IBS is not a one-size-fits-all condition. There are different subtypes of IBS (e.g., IBS-D for diarrhea-predominant or IBS-C for constipation-predominant), and treatment must be customized based on the patient's symptoms and triggers 4 . Emerging research suggests the need to identify distinct subtypes of IBS to guide more effective treatments 2 4 . 3. Dietary Management The low FODMAP diet is a widely recommended dietary intervention for IBS. It helps identify food triggers and manage symptoms but should not be used long-term without personalization 3 . Probiotics may also play a role in symptom relief for some patients, though their effectiveness varies 3 . 4. Behavioral Interventions Cognitive Behavioral Therapy (CBT) and gut-directed hypnotherapy are effective in managing IBS symptoms, particularly when patients are motivated to engage in these therapies 1 . Stress management is critical since stress and anxiety can exacerbate IBS symptoms 1 5 . 5. Pharmacological Therapies Medications are often used as complementary treatments when dietary or behavioral strategies alone are insufficient. These include antispasmodics, laxatives, or medications targeting gut-brain interaction 1 5 . Precision medicine is the future of pharmacological treatment, aiming to match therapies with the underlying causes of an individual's symptoms rather than just addressing the symptoms themselves 1 . 6. Challenges in IBS Management One of the most distressing symptoms for patients is bowel urgency, significantly impacting their quality of life. Research is ongoing to better understand and manage this symptom 2 4 . Pain management remains a critical area for improvement, as existing treatments often provide inadequate relief for abdominal pain and gut hypersensitivity in IBS patients 2 4 . 7. Patient Education and Collaboration Educating patients about the trial-and-error nature of IBS treatment helps set realistic expectations and reduces frustration when initial interventions do not work 1 . Shared decision-making between healthcare providers and patients ensures that treatment plans align with patient preferences and lifestyle. In summary, effective IBS management combines personalized care with dietary, behavioral, and pharmacological strategies within an integrative framework. The podcast underscores the importance of ongoing research to refine treatments and improve outcomes for IBS sufferers.…

I

Ingest

Ingest podcast artwork

1
Abdominal Pain in Children 58:07

il y a 25 weeks58:07

58:07

Charlie Andrews talks to Dr Anthony (Tony) Wisken, Consultant Paediatric Gastroenterologist in Bristol. The Ingest podcast is hosted by Dr Charlie Andrews a GPwER in gastroenterology based near Bath. Charlie works as a GP partner at Somer Valley Medical Group, trained as an endoscopist and leads the national GPwER in gastroenterology training programme, launched in 2023 in the southwest of England. Charlie is a committee member of the PCSG (Primary Care Society of Gastroenterology). For more information visit pcsg.org.uk…

I

Ingest

Ingest podcast artwork

1
Getting It Right First Time. Gastro Innovation in Northumbria 55:46

il y a 28 weeks55:46

55:46

With significant waiting lists and growing demand for secondary care services, Advice and Guidance is being increasingly explored as one potential solution to this problem. In this episode, Charlie Andrews discusses an innovative and extremely successful use of advice and guidance in Northumbria with gastroenterologists Matthew Warren and Richard Thomson. Through the enhanced use of advice and guidance for all incoming referrals for secondary care input, they have demonstrated a significant reduction in waiting times for routine outpatient care. They discuss their advice and guidance model, and what they have learned from developing this service and the impact it has been having on their waiting times, and how it has been received by primary care colleagues (3:30). We go on to discuss some common advice and guidance queries that Matt and Richard see (19:30) and I ask the question - what makes a good advice and guidance query? (43.30).…

I

Ingest

Ingest podcast artwork

1
IBS Part 1 – Diagnosis 42:11

il y a 31 weeks42:11

42:11

Key takeaways from the IBS Part 1 episode of the PCSG Ingest podcast: Diagnosis of IBS The episode is focused on making a diagnosis of Irritable Bowel Syndrome (IBS)and features Dr. Anton Emmanuel, a consultant gastroenterologist and Professor of neuro-gastroenterology at University College Hospital London. Importance for Primary Care IBS is a common condition that primary care clinicians need to have a structured approach to diagnosing. Topics Covered Causes of IBS Different subtypes of IBS Challenges in making a positive diagnosis Clinical Pearls Dr. Emmanuel shares several insights: Key questions to include in the patient history How to describe the condition to patients Practical tips for enhancing IBS diagnosis in primary care Diagnostic Approach The episode emphasises the importance of: Taking a structured approach to diagnosis Understanding the various presentations of IBS Recognizing the challenges in making a definitive diagnosis Patient Communication Guidance is provided on: Explaining IBS to patients effectively Addressing patient concerns and misconceptions Additional Resources The episode mentions useful guidance from the British Society of Gastroenterology, which listeners were encouraged to reference for more detailed information. Part 2 focusing on the management of IBS to be released soon. bsg.org.uk/clinical-resource/british-society-of-gastroenterology-guidelines The Ingest podcast is hosted by Dr Charlie Andrews a GPwER in gastroenterology based near Bath. Charlie works as a GP partner at Somer Valley Medical Group, trained as an endoscopist and leads the national GPwER in gastroenterology training programme, launched in 2023 in the southwest of England. Charlie is a committee member of the PCSG (Primary Care Society of Gastroenterology). For more information visit pcsg.org.uk…

I

Ingest

Ingest podcast artwork

1
High Iron Levels (hyperferritinaemia) 39:18

il y a 38 weeks39:18

39:18

Dr Charlie Andrews speaks to Dr Jeremy Shearman about everything related to high iron levels (hyperferritinaemia). We discuss how iron is regulated within the body, causes of raised iron levels, and then we dive into hereditary haemochromatosis - when to suspect, how to test, who to refer (and to whom!), and how the condition is managed. Useful links to accompany this episode include: Welcome > Haemochromatosis: genetic iron overload disease (exeter.ac.uk) Haemochromatosis - British Liver Trust…

I

Ingest

Ingest podcast artwork

1
Diverticular disease and diverticulitis 22:30

il y a 44 weeks22:30

22:30

In this episode, Charlie Andrews speaks to Melanie Orchard, a consultant surgeon, about diverticular disease and diverticulitis. This is something that we encounter frequently in primary care, and understanding how to approach this condition is extremely important. Melanie discusses a really pragmatic approach to patients with symptoms suggestive of diverticulitis. We discuss risk factors, presenting features, and how to assess the patient with suspected diverticulitis. We also discuss the difference between diverticulosis, diverticular disease and diverticulitis, and give you useful tips on what advice to give to patients who has just had a colonoscopy showing that they have diverticulosis. For a useful visual summary of the management of patients with diverticulosis and diverticulitis, please follow this link: visual-summary-pdf-6968965213 (nice.org.uk)…

I

Ingest

Ingest podcast artwork

1
Hepatitis C 32:08

il y a 51 weeks32:08

32:08

Join Charlie Andrews as he discusses Hepatitis C with hepatologist Dr Kosh Agarwal and GP and clinical champion for Hepatitis C Dr Rik Fijten. They discuss the prevalence and presentation of Hepatitis C, as well as how to test for the condition along with an overview of the treatment options available. Hepatitis C is a chronic liver disease which carries significant morbidity and mortality if left untreated. Fortunately, it is both easy to test for and the treatments available offer a fantastic cure rate of in excess of 95% with simple and relatively short tablet regimens. NHS England has set itself the target of eradicating the disease by 2025 through active case finding, simplifying the diagnostic process, and ensuring pathways are in place to provide rapid and effective treatments for the condition. Resources: For more information on Hepatitis C, the British Liver Trust offers useful patient-friendly leaflets and further information about the condition: Hepatitis C - British Liver Trust The self-testing portal mentioned by Rik during the episode can be found here: Home - HepC (hepctest.nhs.uk)…

I

Ingest

Ingest podcast artwork

1
Neuroendocrine tumours (NETs) of the gastrointestinal tract 31:12

il y a 1 year31:12

31:12

In this episode, Dr Charlie Andrews speaks to Professor Mark Pritchard about neuroendocrine tumours (NETs) of the gastrointestinal tract. You may be asking yourself: 'Do I really need to know about NETs in primary care, aren't they extremely rare?' The answer to that is a resounding yes, you do need to know about NETs and Mark will tell you why in this episode! Neuroendocrine cancer is the 10th most prevalent cancer in England, and the second most prevalent cancer of the GI tract, with a rapidly rising incidence (371%) over the last 20 years. NETs are commonly diagnosed at a more advanced stage due to late diagnosis as the signs and symptoms can be vague, or mimic other more common conditions such as IBS. Mark provides lots of useful, practical advice about when to suspect this form of cancer in primary care, which patients may be a higher risk, and what to do if you are suspicious about this form of cancer in your patient. Listen on to find out more.…

I

Ingest

Ingest podcast artwork

1
Ingest Trailer 2:53

il y a 1 year2:53

2:53

Dr Charlie Andrews, a committee member of the Primary Care Society for Gastroenterology (PCSG), introduces Ingest , the podcast for primary care that focuses on when to suspect, how to diagnose and how to manage common gastrointestinal presentations and conditions.

I

Ingest

Ingest podcast artwork

1
Highlights from Ingest 2023 31:28

il y a 1 year31:28

31:28

In this episode Dr Charlie Andrews looks back at 2023 and highlights some key takeaways from Ingest in 2023.

I

Ingest

Ingest podcast artwork

1
Barrett’s oesophagus 28:21

il y a 1 year28:21

28:21

In this episode, Charlie Andrews speaks to Dr Andrew Moore about this condition, which affects up to 1.5% of the population, with a risk of progression to cancer of 3-13% over the patient's lifetime (Cancer Research UK). They discuss the typical presenting features, who needs an endoscopy to look for Barrett's, and how the condition is managed both in primary and secondary care. The BSG guidelines mentioned by Dr Moore in the episode can be found here: https://www.bsg.org.uk/clinical-resource/bsg-guidelines-on-the-diagnosis-and-management-of-barretts-oesophagus/ For more episodes about the oesophagus, you may find the following episodes of Ingest useful: Dyspepsia, Eosinophilic oesophagitis, Dysphagia and Achalasia. BSG guidelines on the diagnosis and management of Barrett's oesophagus - The British Society of Gastroenterology Fitzgerald RC, di Pietro M, Ragunath K et al. Abstract These guidelines provide a practical and evidence-based resource for the management of patients with Barrett’s oesophagus and related early neoplasia. The Appraisal of Guidelines for Research and Evaluation (AGREE II) […] www.bsg.org.uk…

I

Ingest

Ingest podcast artwork

1
Bile acid diarrhoea 27:37

il y a 2 years27:37

27:37

In this episode, Charlie Andrews speaks to Professor Julian Walters about bile acid malabsorption and diarrhoea. With up to a third of patients with diarrhoea-predominant IBS having underlying bile acid diarrhoea, and with diagnosis rates for this condition being low, this episode is an important one for anyone working in primary care. We explore the role and physiology of bile acids, the causes and symptoms of bile acid malabsorption, the diagnostic tests used to make the diagnosis and the treatment of this common but underdiagnosed condition. Should we use 'trial of treatment' in primary care to support the diagnosis? Are people who have had their gall bladder removed at greater risk of bile acid diarrhoea? Can bile acid sequestrants impact the absorption of other medications? These questions, and lots more, will be discussed in this episode!…

Bienvenue sur Lecteur FM!

Lecteur FM recherche sur Internet des podcasts de haute qualité que vous pourrez apprécier dès maintenant. C'est la meilleure application de podcast et fonctionne sur Android, iPhone et le Web. Inscrivez-vous pour synchroniser les abonnements sur tous les appareils.

Écoutez plus de 500 sujets

Guide de référence rapide

Meilleurs podcasts

Les Grandes Gueules du Sport

Super Moscato Show

Sans rendez-vous - Mélanie Gomez

Entendez-vous l'éco ?

Les Grosses Têtes

Le Billet de Sophia Aram

M2 - Mutation numérique

La session de rattrapage, Jean-Luc Lemoine s’amuse de la télé

La Terre au carré

Sur les épaules de Darwin

Affaires sensibles

Hondelatte Raconte - Christophe Hondelatte

L'Heure Du Crime

CERNO L'anti-enquête

Scènes de Crime

Écoutez cette émission pendant que vous explorez